Ticker Details
IDEAYA Biosciences, Inc.
IPO Date:	May 20, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.68B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.53 | 2.87%
Avg Daily Range (30 D):	$0.86 | 2.60%
Avg Daily Range (90 D):	$0.75 | 2.24%

Institutional Daily Volume
Avg Daily Volume:	.44M
Avg Daily Volume (30 D):	1.02M
Avg Daily Volume (90 D):	.79M

Trade Size
Avg Trade Size (Sh.):	68
Avg Trade Size (Sh.) (30 D):	63
Avg Trade Size (Sh.) (90 D):	57

Institutional Trades
Total Institutional Trades:	2,804
Avg Institutional Trade:	$2.46M
Avg Institutional Trade (30 D):	$3M
Avg Institutional Trade (90 D):	$3.23M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.42M
Avg Closing Trade (30 D):	$7.05M
Avg Closing Trade (90 D):	$6.51M
Avg Closing Volume:	126.45K

News

Apr 13, 2026 @ 11:48 AM IDEAYA Eye Cancer Trial Data Beats Standard Therap... Source: Vandana Singh

Dec 17, 2025 @ 3:00 PM Antibody Optimization Service Market Set to Reach ... Source: Towards Healthcare

Oct 14, 2025 @ 5:00 PM Melanoma Clinical Trial Pipeline Accelerates as 15... Source: Delveinsight

Aug 5, 2025 @ 8:23 PM IDEAYA (IDYA) Q2 Net Loss Improves 27% Source: Jesterai

Jul 22, 2025 @ 5:00 PM Melanoma Market Anticipates a Dynamic Shift During... Source: Delveinsight

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.28	$-.94	$-1.28
Diluted EPS	$-1.28	$-.94	$-1.28
Revenue	$218.71M	$10.88M	$218.71M
Gross Profit
Net Income / Loss	$-113.7M	$-83.27M	$-113.7M
Operating Income / Loss	$-159.31M	$-94.57M	$-159.31M
Cost of Revenue
Net Cash Flow	$28.66M	$-185.89M	$28.66M
PE Ratio